Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

Robert F. Kennedy Jr.’s former running mate Nicole Shanahan is raising the alarm over the emergence of technology powered by artificial intelligence (AI) to develop mRNA “vaccines” for ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

The Stargate Initiative, spearheaded by several tech giants, has raised alarm in the most paranoid parts of the MAGA movement ...

Today on Rising, Robby Soave delivers radar on why Mark Zuckerberg, Elon Musk, Jeff Bezos and others have flocked to President Trump’s side. Robby and Niall Stanage react to key parts of Trump’s ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ ...

The new Applied Model Card from the Coalition for Health AI aims to improve transparency and accountability in health care's growing tech industry. Reducing meetings, addressing app fatigue and ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...